HLP003 nears phase III readout for adjunctive MDD
Help advancing HLP003 in phase III for adjunctive major depressive disorder, with top-line data expected in Q4 2026 and an NDA filing targeted for 2028.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.